đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
This study will determine whether participants who receive the vaccine V419...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-26
Trial ID
NCT01341639
Treatments Being Tested
This study is designed to 1) describe the safety, tolerability, and immunog...
Status
Completed
Location
Bliss Healthcare Services ( Site 0010)
Start Date
2018-07-06
Trial ID
NCT03480802
Treatments Being Tested
This is a phase 3, randomized, double-blind, active comparator-controlled s...
Status
Completed
Location
Central Research Associates ( Site 0067)
Start Date
2022-07-13
Trial ID
NCT05425732
The study is being conducted to demonstrate that V221 may be administered c...
Status
Completed
Location
Multiple Locations
Start Date
2006-03
Trial ID
NCT00109343
This is a study to assess the safety, tolerability, and immunogenicity of V...
Status
Completed
Location
Multiple Locations
Start Date
2011-04-19
Trial ID
NCT01337167
Treatments Being Tested
The purpose of this clinical study is to evaluate the safety and immunogeni...
Status
Completed
Location
Hvidovre Hospital ( Site 0003)
Start Date
2019-08-28
Trial ID
NCT04016714
Treatments Being Tested
The purpose of this clinical study is to evaluate the safety and immunogeni...
Status
Completed
Location
Morinaga Maternity Clinic ( Site 3345)
Start Date
2020-07-01
Trial ID
NCT04384107
Hepatitis A vaccine will be given either alone or together with measles, mu...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00312858
The purpose of this study is to determine whether Zoster Vaccine Live and P...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00535730
The purpose of this study is 1) to evaluate the safety and tolerability of ...
Status
Completed
Location
Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007)
Start Date
2019-06-25
Trial ID
NCT03885934
Treatments Being Tested